Georgios Vavoulis

Mr. Georgios Vavoulis

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2024 in Cureus
Verified
Journal Article
Open access
Georgios VavoulisGeorgios Vavoulis
Georgios Vavoulis
DGDimitrios Giakoumettis
Dimitrios Giakoumettis
ATAbraham Tsitlakidis
Abraham Tsitlakidis
AKAikaterini Karagianni
Aikaterini Karagianni
BABilal Almasarwah
Bilal Almasarwah
KVKonstantinos Vlachos
Konstantinos Vlachos
Spinal dural arteriovenous fistulae (sDAVFs) are rare entities with delayed diagnosis, potentially dramatic clinical manifestations, and complex management. We aim to present our mini case series and perform an updated systematic review of the usual patient profile, to search for established prognostic factors, to compare the effectiveness and safety of surgical and endovascular intervention, and to discuss trends in therapeutic strategy. We retrospectively collected data from patients treated in our department in the last decade (2014-2024) and we systematically reviewed the literature according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria and searched the PubMed database for relevant articles published in the same period. Epidemiologic data, imaging modalities, prognostic factors, and treatment modalities were assessed. Firstly, we identified four illustrative cases from our institution. In addition, our search yielded 559 studies and our review included 82 original studies. 3130 patients were identified (mean age 61; male-to-female ratio 3:1). Most commonly, the fistula level was in the thoracic spine (65%). Surgery was provided to 1837 patients (1213 as primary treatment) and embolism to 1085 (932 as primary treatment). Initial fistula occlusion rate and recurrence rate were 98.1% and 1.9% for surgery and 71.1% and 9.6% for embolism, respectively. No difference between the two modalities with respect to clinical outcome was observed. SDAVFs remain a challenge for neurosurgeons concerning both diagnosis and management. Surgery remains superior to embolism with respect to success as an initial treatment. Embolism can be offered if certain contraindications do not coexist. All symptomatic patients should be offered treatment, whereas asymptomatic patients could be conservatively managed only if the close patient follow-up can be secured.

28 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Panagiotis SkourasPanagiotis Skouras
Panagiotis Skouras
GGGeorgios Giakoumettis
Georgios Giakoumettis
CACHARALAMPOS ARGYROS
CHARALAMPOS ARGYROS
Georgios VavoulisGeorgios Vavoulis
Georgios Vavoulis
EVEmmanouil Verigos
Emmanouil Verigos
DGDimitrios Giakoumettis
Dimitrios Giakoumettis
Background: Oligodendrogliomas are a molecularly distinct subtype of glioma according to the WHO 2021 tumor classification, defined as isocitrate dehydrogenase (IDH) mutations and 1p/19q co-deletion. This updated classification has changed the approach to glioma management by emphasizing the critical role of molecular diagnostics. This study explores current therapeutic strategies for adult oligodendrogliomas and contextualizes findings with a patient with a Grade 3 oligodendroglioma of the hippocampus. Methods: A systematic review was conducted, synthesizing evidence from 36 studies published between 2021 and 2024. The review focuses on surgical resection, PCV chemotherapy (procarbazine, lomustine, vincristine), and radiotherapy, with progression-free survival (PFS) and overall survival (OS) as primary outcomes. Moreover, a 45-year-old woman diagnosed with an IDH-mutant, 1p/19q-co-deleted Grade 3 oligodendroglioma is presented to illustrate clinical management. Results: The review highlights the significance of molecular profiling in personalizing treatment strategies. The findings highlight that maximal safe surgical resection combined with PCV chemotherapy and radiotherapy optimizes PFS and OS. However, our case underwent chemotherapy and radiotherapy after a multidisciplinary consultation, demonstrating favorable initial outcomes. These findings reaffirm the importance of integrating molecular insight into clinical decision-making. Conclusions: Advancements in molecular diagnostics have profoundly enhanced the personalization of therapy for oligodendrogliomas, yielding improved survival outcomes. Optimal management should entail a multidisciplinary approach incorporating surgery, chemotherapy, and radiotherapy, guided by molecular features. This study reinforces the necessity of molecular-driven strategies to improve survival and quality of care for patients with oligodendroglioma.

29 November 2024 in Brain and Spine
Verified
Journal Article
Open access
DGDimitrios Giakoumettis
Dimitrios Giakoumettis
TVT. Vogiatzoglou
T. Vogiatzoglou
Georgios VavoulisGeorgios Vavoulis
Georgios Vavoulis
BAB. Almasarwah
B. Almasarwah
KTK. Tilidou
K. Tilidou
KVK. Vlachos
K. Vlachos
Klippel-Trenaunay Syndrome (KTS) is a rare congenital condition characterized by vascular malformations, bone abnormalities, and limb overgrowth. The genetic basis of KTS is not fully understood, and the diagnosis relies on clinical features. Its clinical spectrum includes several neurosurgical diagnoses, such as cavernous hemangiomas, arteriovenous fistulas, and Chiari I malformation. This study investigates the neurological complications associated with KTS, focusing on its coexistence with Chiari I malformation and other neurosurgical entities, through a systematic review and a case report. A 27-year-old woman with KTS and Chiari I malformation presented with progressive tetraparesis and cranial nerve deficits. Emergency foramen magnum decompression had to be undertaken despite significant coagulation abnormalities. Despite her post-operative period being complicated by splenic rupture requiring splenectomy, she demonstrated gradual neurological recovery. The patient presented with a significant neurological improvement at her 3-month follow-up, being able to walk independently with a stick. A systematic review of the Pubmed database identified 55 patients with KTS requiring neurosurgical attention. The most common pathology was vascular malformations, followed by CNS tumors, whereas Chiari malformation was rare. The study highlights the challenges of managing patients with KTS and Chiari I malformation, emphasizing the importance of early diagnosis, through preoperative evaluation and interdisciplinary care. Emergency surgery in KTS patients with neurological deterioration, though high risk, can improve outcomes with careful coordination among neurosurgeons, hematologists, and internists. The rare association of Chiari I malformation with KTS underscores the need for vigilance and a tailored approach to care.

12 May 2026 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
Georgios VavoulisGeorgios Vavoulis
Georgios Vavoulis
DSDimitrios Spinos
Dimitrios Spinos
PVPanagiotis Varoutis
Panagiotis Varoutis
GGGeorgios Georgountzos
Georgios Georgountzos
NKNina Rafailia Karela
Nina Rafailia Karela
WCWai Sum Cho
Wai Sum Cho
Introduction: The perioperative management of spontaneous cerebrospinal fluid leaks (sCSFL) of lateral skull base remains under debate. We systematically synthesized and evaluated the current literature, to investigate the perioperative cranial‐pressure assessment protocols and relief methods. The assessment corresponded to fulfillment of criteria for idiopathic intracranial hypertension (IIH) or otherwise defined in the study. Relief methods included either medical, that is, acetazolamide, or invasive, that is, lumbar puncture (LP) or drain (LD) or ventriculoperitoneal shunt (VPS). Methods: Selected studies concerned surgical treatment of lateral sCSFL. Data extracted included the following: study characteristics, patient characteristics, primary outcomes, and secondary outcomes. Data sources: MEDLINE, EMBASE, and Cochrane Library. Results: Baseline data were calculated from 2039 operations, out of which 423 had perioperative LP or LD. When only studies which mentioned recurrence or persistence rates were considered, 262 of them were used routinely or in selected patients and 117 occasionally. In those two cohorts, recurrence or persistence rates were similar (10.1% vs. 8.9%). Intracranial pressure was assessed in 335 patients from 10 studies and 48 among them were diagnosed with IIH (14.3%). Acetazolamide was inconsistently used in 17.7% of cases. From 18 studies that reported the use of VPS, this was used in 11.2% of the cases. Discussion: Systematic perioperative LP or LD use does not affect the recurrence or persistence rates. However, decision making with respect to the use of LP or LD is inconsistently reported in the literature. The same issue holds for the use of acetazolamide or VPS. Assessment of intracranial hypertension is usually neglected, and when used, not standardized. Level of Evidence: 2